Vaccine waiver talks can make drug firms the heroes, U.S. trade chief says

U.S. Trade Representative Katherine Tai said on Wednesday she is pushing for a waiver of COVID-19 vaccine intellectual property rights because the United States and drug makers have "an obligation to help save the world right now."